Literature DB >> 1360519

Non-Michaelis-Menten type hepatic uptake of liposomes in the rat.

H Harashima1, Y Kume, C Yamane, H Kiwada.   

Abstract

The objective of this study was to verify the methodology for measuring uptake clearance of liposomes and to characterize kinetically the saturable hepatic uptake of liposomes-through phagocytosis. The correction of vascular space was important in the evaluation of hepatic uptake. The efflux of liposomes from liver was shown to be negligible, by a repeated dose study, and thus, hepatic clearance can be obtained by the hepatic uptake divided by the area under the blood concentration-time curve (AUC). The determinant parameter which describes the saturability of uptake clearance of liposomes, independent of infusion rate, was investigated, using the data of an in-vivo constant infusion study, where infusion rate-dependent saturable hepatic clearance was observed. The mean blood concentration failed to obtain an infusion rate-independent function. On the other hand, the AUC could explain the saturability of hepatic clearance for every infusion rate by a unique relationship. The hepatic uptake amount could also explain this saturability, independent of infusion rate. These kinetic characteristics are inconsistent with Michaelis-Menten type kinetics, therefore a new model is required to describe the saturable hepatic clearance in the disposition of liposomes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1360519     DOI: 10.1111/j.2042-7158.1992.tb05504.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  6 in total

1.  Distinction between the depletion of opsonins and the saturation of uptake in the dose-dependent hepatic uptake of liposomes.

Authors:  H Harashima; K Sakata; H Kiwada
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

2.  Dual physiologically based pharmacokinetic model of liposomal and nonliposomal amphotericin B disposition.

Authors:  Leonid Kagan; Pavel Gershkovich; Kishor M Wasan; Donald E Mager
Journal:  Pharm Res       Date:  2013-06-21       Impact factor: 4.200

3.  Synergistic effect between size and cholesterol content in the enhanced hepatic uptake clearance of liposomes through complement activation in rats.

Authors:  H Harashima; T M Huong; T Ishida; Y Manabe; H Matsuo; H Kiwada
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

4.  Rates of systemic degradation and reticuloendothelial system (RES) uptake of thermosensitive liposome encapsulating cisplatin in rats.

Authors:  K Iga; Y Ogawa; H Toguchi
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

5.  Kinetic analysis of AUC-dependent saturable clearance of liposomes: mathematical description of AUC dependency.

Authors:  H Harashima; C Yamane; Y Kume; H Kiwada
Journal:  J Pharmacokinet Biopharm       Date:  1993-06

6.  Effective irinotecan (CPT-11)-containing liposomes: intraliposomal conversion to the active metabolite SN-38.

Authors:  Y Sadzuka; S Hirotsu; S Hirota
Journal:  Jpn J Cancer Res       Date:  1999-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.